Intravascular histiocytosis: case report of a rare disease probably associated with silicone breast implant,
AUTOR(ES)
Abuawad, Yasmin Gama; Diniz, Ticiana de Andrade Castelo Branco; Kakizaki, Priscila; Valente, Neusa Yuriko Sakai
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2020-06
RESUMO
Abstract Intravascular histiocytosis is a rare condition characterized by the aggregate of histiocytes within dilated dermal vessels. The diagnosis is mainly histophatological and immunohistochemical. We describe a case of a 55 year-old female patient presenting erythematous/purple patches on the breasts, back and limbs. She previously presented ductal carcinoma in the right breast in 2006 which was treated with mastectomy and proceeded to silicone breast implant in 2009. Clinical hypothesis was telangiectatic metastatic carcinoma. Histopathology showed vascular ectasia, thrombosis and recanalization of upper dermis small vessels. On immunohistochemistry, intravascular cells were CD 68+ and negative for estrogen and progesterone receptors, CK7, EMA and AE1/AE3 and endothelial cells were CD64+, leading to the diagnosis of intravascular histiocytosis.
Documentos Relacionados
- Congenital Langerhans cell histiocytosis: a good prognosis disease?
- Progressive spinocerebellar degeneration "plus" associated with Langerhans cell histiocytosis: a new paraneoplastic syndrome?
- The Langerhans cell histiocytosis: a disease in search of an identity
- Sinus Histiocytosis with Massive Lymphadenopathy (Rosai-Dorfman Disease): A Case Report and Literature Review
- Scleroderma, primary biliary cirrhosis, and Sjögren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease.